Natural killer cell-based immunotherapeutic strategies

Area of Science:

• Immunology
• Cellular Therapy
• Oncology

Background:

• Natural killer (NK) cells are gaining prominence as a cellular therapy for malignant diseases, moving beyond the traditional focus on T-cells.
• Recent discoveries of specific NK cell receptors interacting with target cell HLA molecules and activating receptors have fueled this evolution.
• NK cells constitute approximately 10% of peripheral blood lymphocytes, necessitating efficient separation and enrichment for clinical applications.

Purpose of the Study:

• To review the requirements for natural killer (NK) cell-mediated target cell recognition.
• To discuss methods for ex vivo expansion of NK cells for therapeutic purposes.
• To explore the potential therapeutic applications of NK cells in malignant diseases.

Main Methods:

• Literature review focusing on NK cell biology, receptor interactions, and clinical trial data.
• Analysis of separation and enrichment techniques for NK cell isolation.
• Synthesis of information on ex vivo expansion protocols and therapeutic strategies.

Main Results:

• NK cell recognition is mediated by specific activating and inhibitory receptors interacting with target cell ligands, notably HLA molecules.
• Efficient ex vivo expansion methods are crucial for generating sufficient NK cell numbers for clinical use.
• Potential therapeutic applications include various hematological malignancies and solid tumors, with ongoing research into allogeneic NK cell infusions.

Conclusions:

• NK cells represent a viable and evolving cellular therapy for cancer treatment.
• Understanding NK cell recognition mechanisms and optimizing ex vivo expansion are key to their clinical success.
• Careful consideration of T-cell contamination is essential in allogeneic NK cell therapy to prevent graft-versus-host disease.